Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EVEROLIMUS (WITH 0.2% BHT), with a corresponding US DMF Number 29651.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 15, 2015, and payment made on September 22, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II